Trial intelligence / Profile preview

rHGH for Knee Osteoarthritis

NCT07036003Phase 2Active, not recruiting

Start
Oct 2025
Primary completion
Jul 2028
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 2 trial of somatropin in knee osteoarthritis (OA). Started Oct 2025; status: active, not recruiting.

02

Drugs

somatropin
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07036003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07036003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call